Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Distributing De Novo Software

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Molecular Devices will distribute De Novo Software's FCS Express 4 software under a licensing agreement announced today.

Under the terms of the deal, Molecular Devices will distribute the software to customers in the research and pharmaceutical markets worldwide. Further terms of the deal were not disclosed.

In FCS Express 4, analytical tools for flow and image cytometry and high-content screening are combined in one environment with report generation and online collaboration tools, the companies said. The software, which was launched by De Novo in January, adds the ability to access and interactively perform population-based analysis, while linking back to the individual images underlying the data.

"This enables highlighting of individual cells in an image from selected populations or display of single cells of interest in separate cell galleries," Molecular Devices and De Novo said in a joint statement. The tools improve assay development and workflow and enable rapid report generation, they added.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.